Aidoc Raises $150m to Continue Innovating Medical Diagnostics

AIDOC, a medical technology company, has collected $ 150 million from supporters, including General Catalyst to continue to develop medical diagnostic technology. AIDOC currently serves more than 45 million patients a year and aims to ensure that technology will meet and detect each disease within three years. AIDOC CEO Elad Walach, who closed the latest financing tour, spoke to Tom Mackenzie with ‘Bloomberg: The Pulse’.